GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of switched from 0.5mg to 1.0mg and early fullness got better, not worse — 36 comments in the full submission. View in context.
828
c/tapering·submitted 1 year ago by u/naomi_ekstrom

switched from 0.5mg to 1.0mg and early fullness got better, not worse

Regainbranch of 8 comments

switched from 0.5mg to 1.0mg and early fullness got better, not worse. Not a hot take, just something I have not seen said plainly here. 0.5mg and 1.0mg. Those are measured, not estimated, and not rounded up in my favour. A written baseline — dose, date, weight, waist, and how appetite feels — taken before any change…

Read the full submission and all 36 comments →

This branch

8 comments, started 1 year ago
u/rafael_sjoberg-34 points·1 year ago

Nothing on this board is a taper schedule, and no member can write one for another. What can be shared is what people watched and what they observed.

replysharereportpermalink
u/janek_ferrari1 point·1 year ago

How long were you at the dose you are coming off?

replysharereportpermalink
u/cormac_roos1 point·1 year ago

stopping is a plan, not an event

replysharereportpermalink
u/naomi_ekstromOP1 point·1 year ago

What is prompting the decision — cost, supply, side effects, or something else?

replysharereportpermalink
u/maren_baptista1 point·1 year ago

the habits are what has to carry it afterwards

replysharereportpermalink
u/naomi_ekstromOP-40 points·1 year ago

Stretching the interval or reducing the dose?

replysharereportpermalink
u/naomi_ekstrom1 point·1 year ago

Correcting myself upthread: appetite returned at week 24 for me, not the week I posted.

replysharereportpermalink
u/zeynep_zielinski1 point·1 year ago

Push back: that is a taper schedule aimed at another member and this board does not host those.

replysharereportpermalink

← back to the whole thread

About c/tapering

Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.

20kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/tapering
c/tapering rules
  1. Cite the discontinuation data rather than guessing at regain rates.
  2. No shaming people who restart.
  3. Say how long you were on and at what dose before you tapered.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/taper_off_tabithau/maintenance_mode_maxu/skip_week_sceptic
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →